Sex-based effectiveness in buprenorphine/naloxone and methadone treatment for opioid use disorder: Findings from the OPTIMA trial
PsiquiatriaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Drug and alcohol dependence
- Publicado em
- 7 mai 2026
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Sex-based effectiveness in buprenorphine/naloxone and methadone treatment for opioid use disorder: Findings from the OPTIMA trial
Christina McAnulty, Gabriel Bastien, Cédric Pek, Tess Pelletier McCrea, Anne Bouthillier, Sherry H Stewart, M Eugenia Socias, Bernard Le Foll, Didier Jutras-Aswad, OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse
Descritores MeSH
- Opiate Substitution Treatment
- Buprenorphine
- Methadone
- Naloxone
- Narcotic Antagonists
- Opioid-Related Disorders
- Sex Characteristics
- Buprenorphine, Naloxone Drug Combination
- Middle Aged
- Treatment Effect Heterogeneity
Veja também
Estudos relacionados
- Repeated measures analysis of opioid use disorder treatment on clinical opiate withdrawal scale in a randomized clinical trial: sex differences
- Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan-Canadian, randomized control trial
- Associations of Methadone and BUP/NX Dose Titration Patterns With Retention in Treatment and Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: Secondary Analysis of the OPTIMA Study
- Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial